The first optogenetic "Chimeric Rhodopsin" gene therapy tested in humans. RV-001 starting dose was generally well tolerated in this open-label trial.
02-14
Mitel CEM consolidates risk intelligence,communication,and operational workflows into a single dashboard to streamline decision-making and ensure a coordinated response to any event.
02-14
SHANGHAI,Feb. 13,2025-- Jinxin Technology Holding Company (the "Company") (Nasdaq: NAMI),an innovative provider of digital-content products and services in China,today announced an in-depth
02-14
PETALING JAYA,Malaysia,Feb. 14,2025-- As people live longer,ensuring a purposeful and fulfilling life becomes even more important.Life expectancy in Malaysia has steadily increased to 76.26 years ([1]
02-14
MILPITAS,Calif.,Feb. 13,2025-- In the second half of 2024,worldwide silicon wafer demand started to recover from the industry downcycle seen in 2023,the SEMI Silicon Manufacturers Group (SMG) reporte
02-14
RIYADH,Saudi Arabia,Feb. 13,2025-- EDF Saudi Arabia and TAQA Geothermal Energy Company have signed a strategic Memorandum of Understanding (MoU) to collaborate on geothermal energy technologies inclu
02-14
New Donner OURA™ Series of digitalpianos blends Scandinavian minimalist design high-quality sounds ANAHEIM,Calif.,Feb. 14,2025--Donner,a leader in musical instrument innovation,has officially launch
02-14
NEW YORK,Feb. 13,2025-- The New York Stock Exchange (NYSE) is proud to offer a daily pre-market update directly from the NYSE Trading Floor. Access today\'s NYSE Pre-market update for market insight
02-14
SINGAPORE,Feb. 11,2025-- Brilliance Capital Pte. Ltd.is delighted to present a rare and exceptional opportunity to acquire five adjoining freehold conservation shophouses strategically located in the
02-13
LISHUI,China,Feb. 11,2025-- Tantech Holdings Ltd (NASDAQ: TANH) ("Tantech" or the "Company"),announced today that the Company\'s Board of Directors approved on January 21,2025 to e
02-13
Cangxi County Holds 2026 New Year's Cultural Performance for the Public
The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange
Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement
©copyright 2009-2020 Singapore Info Map
